Cellvera
Cellvera is a biopharmaceutical company focused on developing and commercializing antiviral therapies to transform patients’ lives. Cellvera holds exclusive worldwide rights to Qifenda (Favipiravir) 400mg/800mg and the injectable formulation. This broad-spectrum therapeutic has shown antiviral effects against SARS-CoV-2 (the virus responsible for causing COVID-19) and more than 20 other RNA viruses. Favipiravir is a broad-spectrum antiviral in oral tablet form, initially developed by FujiFilm Toyama in Japan, as a potent and broad-spectrum antiviral. The drug was approved in Japan in 2014 to treat pandemic influenza. The antiviral medication is effective against 12 families of viruses, including Coronaviruses (COVID, MERS, SARS), Filoviruses (EBOLA, MARBURG), Flaviviruses (ZIKA, WEST NILE, DENGUE), RABIES, NOROVIRUS, and many others.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
6
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
3
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Cellvera
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
Showing 1 of 3 verified contacts
Top roles at Cellvera
3 distinct titles indexed · top 3 shown.
- 1business development executive
- 1chief marketing officer
- 1head of corporate services
Sign up to unlock all 3 contacts at Cellvera
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Cellvera
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.